Our commitment to quality

We ensure our content is always unique, unbiased, supported by evidence. Each piece is based on a review of research available at the time of publication and is fact-checked and medically reviewed by a topic expert.

  • Written by: Kyla Reda

  • Medically reviewed by: Lara Zakaria PharmD, CNS, IFMCP

The gut-brain axis is a bidirectional communication network that highlights the importance of gut health in regulating the body’s stress response and adrenal function. Keep reading to learn about the role of the microbiome and how to approach laboratory analysis comprehensively to support your patients.

How gut health impacts the stress response

The gut microbiome consists of trillions of microorganisms that play a crucial role in endocrine functions, including the adrenal glands. (Rusch 2023) The adrenal glands produce hormones such as cortisol, which is vital for the stress response.

A healthy gut microbiome supports the adrenal glands by regulating the hypothalamic-pituitary-adrenal (HPA) axis, the central stress response system. (Rusch 2023) Beneficial gut bacteria produce short-chain fatty acids (SCFAs) like butyrate, which have anti-inflammatory properties and help maintain the integrity of the gut lining. (Shin 2023) A robust gut lining prevents endotoxins from entering the bloodstream and triggering systemic inflammation, which can dysregulate the HPA axis and impair adrenal function. (Mohammad 2021)(Ahmad 2021)

However, an imbalance in the gut microbiome, known as dysbiosis, can disrupt the HPA axis. Dysbiosis often leads to increased intestinal permeability, commonly referred to as "leaky gut." This condition allows harmful substances to pass into the bloodstream, causing chronic low-grade inflammation and placing additional stress on the adrenal glands. (Aleman 2023) Over time, chronic stress and inflammation can lead to adrenal fatigue or dysfunction, impairing the body's ability to respond effectively to stress. (Hannibal 2014)

Both weight gain and weight loss can be associated with cortisol level imbalances. 

The role of the microbiome on cortisol levels

Cortisol, the primary stress hormone produced by the adrenal glands, plays a critical role in regulating metabolism, the immune response, and inflammation. The gut microbiome influences cortisol production through various mechanisms. For instance, certain gut bacteria can produce neurotransmitters like gamma-aminobutyric acid (GABA) and serotonin, which modulate the HPA axis and cortisol secretion. (Rusch 2023)

Dysbiosis can lead to altered cortisol levels, either by increasing or decreasing its production. (Rusch 2023) Over time, chronic stress and elevated cortisol levels are associated with various health issues, including hypertension, insulin resistance, weight gain, heart attack, stroke, diabetes, and neurological problems like memory loss and mood changes. (NIDDK 2023) On the other hand, decreased cortisol levels can cause weight loss, chronic fatigue, muscle weakness, and loss of appetite. (NIDDK 2022)

The role of the microbiome in inflammation

Inflammation is another critical aspect influenced by the microbiome. A healthy gut microbiome produces anti-inflammatory metabolites, helping to regulate the body's inflammatory response. Dysbiosis disrupts this balance, leading to increased production of pro-inflammatory cytokines. (CDC 2024) Chronic inflammation can damage the body’s glucocorticoid receptor, increasing cortisol dysfunction. (Hannibal 2014)

Signs of microbiome imbalance affecting adrenal health

Recognizing the signs of microbiome imbalance is essential for identifying potential impacts on adrenal health.

Anxiety and mood disorders

The gut-brain axis plays a crucial role in mental health. Dysbiosis can affect neurotransmitter production, leading to symptoms of anxiety, depression, and mood swings. (Clapp 2017) These symptoms often coexist with adrenal dysfunction. (NIDDK 2022)

Digestive issues

Persistent digestive problems such as bloating, gas, diarrhea, constipation, and food intolerances often indicate gut dysbiosis. (Wei 2021) These issues can signal an imbalance in gut bacteria, affecting nutrient absorption and overall gut health.

Fatigue

Chronic fatigue is a hallmark symptom of adrenal dysfunction. (NIDDK 2022) Dysbiosis can contribute to fatigue by disrupting cortisol production, altering circadian rhythm, impacting sleep quality, increasing inflammation, and impairing nutrient absorption. (Rusch 2023)

Frequent infections

Since the gut and microbiome balance play a significant role in immune system balance, a compromised gut microbiome weakens the immune system, making those with dysbiosis more susceptible to infections. Frequent colds, flu, and other infections can indicate both gut and adrenal health issues. (Wiertsema 2021)

Skin problems

Conditions such as acne, eczema, and psoriasis can be linked to gut dysbiosis and chronic inflammation, both of which affect adrenal health. (Widhiati 2021) Stress can also exacerbate skin reactions. (Lambert 2022)

Conditions related to dysbiosis and adrenal dysfunction

Several conditions are associated with both gut dysbiosis and adrenal dysfunction, highlighting the interconnectedness of these systems.

Autoimmune disorders

Conditions such as rheumatoid arthritis, lupus, and inflammatory bowel disease (IBD) involve chronic inflammation and immune dysregulation. (Xiang 2023) Both dysbiosis and adrenal dysfunction can exacerbate these conditions by perpetuating inflammation and stress.

Chronic fatigue syndrome

Chronic fatigue syndrome (CFS) is a complex disorder involving severe fatigue and other symptoms. (CDC 2024) Dysbiosis and adrenal dysfunction are frequently observed in individuals with CFS, suggesting a multifactorial etiology involving gut health and stress response. (Deumer 2021)

Chronic fatigue is linked to both gut dysbiosis and adrenal dysfunction. 

Fibromyalgia

This condition is characterized by widespread musculoskeletal pain and fatigue. Similar to CFS, fibromyalgia patients are often found to have dysbiosis and HPA axis abnormalities, implicating gut-adrenal interactions. (Clos-Garcia 2019)

Irritable bowel syndrome

Irritable bowel syndrome (IBS) is a common condition characterized by chronic digestive issues. It's often associated with dysbiosis and has been linked to abnormal cortisol levels and HPA axis dysfunction. (Shaikh 2023)

Lab test assessments

Accurate diagnosis is crucial for addressing microbiome imbalances and adrenal dysfunction. Various diagnostic tests can provide valuable insights to help support patient outcomes.

Hormone panels

Comprehensive hormone panels, including blood or saliva tests, evaluate adrenal hormones (cortisol, DHEA) and sex hormones (estrogen, progesterone, testosterone). These tests help assess overall endocrine function and identify imbalances affecting adrenal health. (NICHD 2017)

Organic acids test (OAT)

This test analyzes urine for organic acids, which are metabolic byproducts. It provides insights into gut dysbiosis, nutrient deficiencies, catecholamine markers, and mitochondrial function, helping to uncover underlying factors contributing to adrenal dysfunction. (Lord 2008)(Rogers 2006)

Saliva tests for cortisol

Salivary cortisol testing measures cortisol levels at different times of the day, providing a comprehensive view of adrenal function and circadian rhythm. It helps identify abnormal cortisol patterns associated with stress, adrenal fatigue, and HPA axis dysregulation. (Kobayashi 2017)(Langelaan 2018)

Stool analysis

Comprehensive stool analysis evaluates the composition and function of the gut microbiome. It identifies beneficial and pathogenic bacteria, as well as yeast overgrowth. This test helps pinpoint dysbiosis and guides targeted interventions to restore gut health. (Alagiakrishnan 2024)

Supporting microbiome and adrenal health

By recognizing the signs of microbiome imbalance and understanding its impact on adrenal function, healthcare providers can implement personalized treatment plans to restore gut health and support adrenal resilience in patients.

Ready to start gathering better clinical context?

Order, manage and review diagnostic testing easier than ever before on Fullscript.

About the contributors

Kyla Reda

Health and Medical Writer

Kyla graduated from Carleton University with a Bachelor’s degree in English Literature and History, and she volunteers as a blog writer and editor for the Ottawa Design Club in her spare time. She is passionate about wellness and sustainability.

Lara Zakaria , PharmD, MS, CDN, CNS, IFMCP

Fullscript Medical Advisor

Dr. Lara Zakaria is a Pharmacist, Nutritionist, and professor specializing in Functional Medicine and Personalized Nutrition. In addition to running a clinical practice focused on providing patients with sustainable solutions that address chronic disease, she also spends her time teaching and mentoring clinicians interested in implementing nutrition and food as medicine principles into practice.

References

  1. Ahmad, M. H., Rizvi, M. A., Fatima, M., & Mondal, A. C. (2021). Pathophysiological implications of neuroinflammation mediated HPA axis dysregulation in the prognosis of cancer and depression. Molecular and Cellular Endocrinology, 520, 111093. https://doi.org/10.1016/j.mce.2020.111093 

  2. Alagiakrishnan, K., Morgadinho, J., & Halverson, T. (2024). Approach to the diagnosis and management of dysbiosis. Frontiers in Nutrition, 11. https://doi.org/10.3389/fnut.2024.1330903 

  3. Aleman, R. S., Moncada, M., & Aryana, K. J. (2023). Leaky gut and the ingredients that help treat it: a review. Molecules, 28(2), 619. https://doi.org/10.3390/molecules28020619 

  4. Bander, Z. A., Nitert, M. D., Mousa, A., & Naderpoor, N. (2020). The Gut Microbiota and inflammation: An Overview. International Journal of Environmental Research and Public Health, 17(20), 7618. https://doi.org/10.3390/ijerph17207618 

  5. CDC. (2024) Symptoms of myalgic Encephalomyelitis/Chronic fatigue syndrome. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. https://www.cdc.gov/me-cfs/signs-symptoms/index.html 

  6. Clapp, M., Aurora, N., Herrera, L., Bhatia, M., Wilen, E., & Wakefield, S. (2017). Gut microbiota’s effect on mental health: The Gut-Brain axis. Clinics and Practice, 7(4), 987. https://doi.org/10.4081/cp.2017.987 

  7. Clos-Garcia, M., Andrés-Marin, N., Fernández-Eulate, G., Abecia, L., Lavín, J. L., Van Liempd, S., Cabrera, D., Royo, F., Valero, A., Errazquin, N., Vega, M. C. G., Govillard, L., Tackett, M. R., Tejada, G., Gónzalez, E., Anguita, J., Bujanda, L., Orcasitas, A. M. C., Aransay, A. M., . . . Falcón-Pérez, J. M. (2019). Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine, 46, 499–511. https://doi.org/10.1016/j.ebiom.2019.07.031 

  8. Deumer, U., Varesi, A., Floris, V., Savioli, G., Mantovani, E., López-Carrasco, P., Rosati, G. M., Prasad, S., & Ricevuti, G. (2021). Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): an overview. Journal of Clinical Medicine, 10(20), 4786. https://doi.org/10.3390/jcm10204786 

  9. Hannibal, K. E., & Bishop, M. D. (2014). Chronic Stress, cortisol dysfunction, and pain: A Psychoneuroendocrine Rationale for Stress management in Pain Rehabilitation. Physical Therapy, 94(12), 1816–1825. https://doi.org/10.2522/ptj.20130597 

  10. Kobayashi, H., Song, C., Ikei, H., Park, B., Kagawa, T., & Miyazaki, Y. (2017). Diurnal changes in distribution characteristics of salivary cortisol and immunoglobulin A concentrations. International Journal of Environmental Research and Public Health, 14(9), 987. https://doi.org/10.3390/ijerph14090987 

  11. Lambert, A. (2022, December 21). Stress and eczema. National Eczema Society. https://eczema.org/information-and-advice/triggers-for-eczema/stress-and-eczema/ 

  12. Langelaan, M. L. P., Kisters, J. M. H., Oosterwerff, M. M., & Boer, A. (2018). Salivary cortisol in the diagnosis of adrenal insufficiency: cost efficient and patient friendly. Endocrine Connections, 7(4), 560–566. https://doi.org/10.1530/ec-18-0085 

  13. Lord, R. S., & Bralley, J. A. (2008). Clinical applications of urinary organic acids. Part 2. Dysbiosis markers. Alternative Medicine Review, 13(4), 292–306. https://pubmed.ncbi.nlm.nih.gov/19152477 

  14. Mohammad, S., & Thiemermann, C. (2021). Role of metabolic endotoxemia in systemic inflammation and potential interventions. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.594150 

  15. NICHD. (2017) How do health care providers diagnose adrenal gland disorders? National Institute of Child Health and Human Development. https://www.nichd.nih.gov/health/topics/adrenalgland/conditioninfo/diagnosed#:~:text=Blood%20and%20urine%20tests%20help,determining%20whether%20it%20is%20cancerous

  16. NIDDK. (2023).Cushing’s Syndrome. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/endocrine-diseases/cushings-syndrome 

  17. NIDDK. (2022). Symptoms & Causes of Adrenal Insufficiency & Addison’s Disease. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/endocrine-diseases/adrenal-insufficiency-addisons-disease/symptoms-causes 

  18. Rogers, S. A. (2006). Using organic acids to diagnose and manage recalcitrant patients. Alternative Therapies in Health and Medicine, 12(4), 44. https://pubmed.ncbi.nlm.nih.gov/16862742/ 

  19. Rusch, J. A., Layden, B. T., & Dugas, L. R. (2023). Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1130689 

  20. Shaikh, S. D., Sun, N., Canakis, A., Park, W. Y., & Weber, H. C. (2023). Irritable Bowel Syndrome and the gut microbiome: A Comprehensive review. Journal of Clinical Medicine, 12(7), 2558. https://doi.org/10.3390/jcm12072558 

  21. Shin, Y., Han, S., Kwon, J., Ju, S., Choi, T., Kang, I., & Kim, S. (2023). Roles of Short-Chain fatty acids in inflammatory bowel Disease. Nutrients, 15(20), 4466. https://doi.org/10.3390/nu15204466 

  22. Wei, L., Singh, R., Ro, S., & Ghoshal, U. C. (2021). Gut microbiota dysbiosis in functional gastrointestinal disorders: Underpinning the symptoms and pathophysiology. JGH Open, 5(9), 976–987. https://doi.org/10.1002/jgh3.12528 

  23. Widhiati, S., Purnomosari, D., Wibawa, T., & Soebono, H. (2021). The role of gut microbiome in inflammatory skin disorders: a systematic review. Dermatology Reports. https://doi.org/10.4081/dr.2022.9188